BioSpace News Archive

Drug Development

The “Magic Word” That Can Trigger a Drugmaker’s Stock to Soar

A look at the lucky drugs that have been hailed a breakthrough by the FDA.

January 8, 2018
·
1 min read
Business

Pfizer Quits Neuroscience R&D

As a result, the company will cut 300 jobs, primarily in Massachusetts and Connecticut.

January 8, 2018
·
1 min read
Business

Celgene Makes Buy to Cure the Biotech Blues

Will this new buy be enough for Celgene investors?

January 8, 2018
·
1 min read
Business

The Latest Biotech Startups to Watch

A look at the latest startups that have emerged in 2018 so far.

January 8, 2018
·
1 min read
BioCapital

Can 2018 Possibly Rival 2017’s Biotechs Record Venture Capital Splurge?

A look at whether big money and big deals will be in store for 2018.

January 8, 2018
·
2 min read
·
Karl Thiel
Policy

Bill Ackman and Valeant’s Bumpy Ride

Just before ringing in the new year, Valeant has managed to resolve another crisis.

January 8, 2018
·
1 min read
FDA

Will 2018 Be Another Record Year for FDA Approvals?

2017 was the second-best year for FDA approvals since 1996.

January 8, 2018
·
1 min read
Drug Development

Biotech Unicorn Moderna Details Game Plan, Reveals Infectious Disease Programs

Moderna unleashed a torrent of updates yesterday.

January 8, 2018
·
2 min read
·
Mark Terry